EUVIMEDEUVIMED entdecken
Crossref

Anti-inflammatory oligosaccharide licensed mesenchymal stem cells allow prolonged survival of septic rats via the promotion of glutathione synthesis

Qingtong Yu, Linzhi Zhang, Zhe Wang, Qilong Wang, Xuan Sun, Wenwen Deng, Xia Cao, Jiangnan Yu, Ximing Xu

Phytomedicine · 2024

DOI: 10.1016/j.phymed.2024.156173 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Phytomedicine, 2024. Verfasst von Qingtong Yu und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Jiangsu University, 212013, ZhenJiang, PR China. Hauptthemen laut MEDLINE: Oligosaccharides, Mesenchymal Stem Cells, Sepsis, Anti-Inflammatory Agents. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Natural Science Foundation of Jiangsu Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Mesenchymal stem cells (MSCs) possess the capability to mitigate multiorgan failure (MOF) and reduce mortality rates in sepsis. However, their survival is significantly limited due to oxidative stress responses triggered by excessive sepsis inflammation. Previous studies have demonstrated that the paracrine effect of MSCs can be enhanced by cytokine stimuli such as IL-1β, TNF-α, and IFN-γ, a process known as inflammatory licensing. This enhancement, however, may potentially lead to the apoptosis of MSCs. PURPOSE: To investigate the therapeutic effects of Fructus Lycii oligosaccharide (FLO)-nasal mucosa-derived ectodermal MSCs (EMSCs) on septic rats and the underlying mechanisms. STUDY DESIGN AND METHODS: FLO was screened from 21 distinct saccharides derived from traditional Chinese medicine (TCM), utilizing macrophage lipid raft chromatography prepared by our laboratory as the primary screening method.. The comparison of EMSCs primed with/without FLO was assessed through RNA-seq. Cecal ligation and puncture (CLP) surgery was performed in the CLP, EMSCs, and FLO-EMSCs groups (n = 10). The NC group underwent cecal ligation without puncture. The therapeutic effects of EMSCs and FLO-EMSCs on septic rats were evaluated through multiple tests including RT-PCR, western blot, histochemical staining, etc. RESULTS: FLO promoted M2 polarization of macrophages and enhanced the paracrine effect of EMSCs, without inducing apoptosis. Furthermore, FLO promoted GSH synthesis in EMSCs, aiding in the removal of reactive oxygen species (ROS) within these cells. The FLO-treated EMSCs demonstrated enhanced protection against pyroptosis in macrophages, thereby preventing immune paralysis during sepsis. CONCLUSION: This study presents an innovative approach for enhancing the anti-inflammatory properties of MSCs using a TCM-derived oligosaccharide, thereby improving their therapeutic efficacy in sepsis models.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OligosaccharidesMesenchymal Stem CellsSepsisAnti-Inflammatory AgentsRats, Sprague-DawleyGlutathioneAnimalsMaleRatsDrugs, Chinese HerbalMesenchymal Stem Cell TransplantationApoptosisDisease Models, AnimalOxidative Stress

Stichwörter der Autor:innen

FLOGSHGlycolysisMSCsSepsis

Substanzen

OligosaccharidesAnti-Inflammatory AgentsGlutathioneDrugs, Chinese Herbal

Autor:innen und Institutionen

  • School of Pharmacy, Jiangsu University, 212013, ZhenJiang, PR China.
  • School of Pharmacy, Jiangsu University, 212013, ZhenJiang, PR China. Electronic address: yjn@ujs.edu.cn.
  • School of Pharmacy, Jiangsu University, 212013, ZhenJiang, PR China. Electronic address: xmxu@ujs.edu.cn.

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • Natural Science Foundation of Jiangsu Province

Zitieren

APA

Yu, Q., Zhang, L., Wang, Z., Wang, Q., Sun, X., Deng, W., Cao, X., Yu, J., & Xu, X. (2024). Anti-inflammatory oligosaccharide licensed mesenchymal stem cells allow prolonged survival of septic rats via the promotion of glutathione synthesis. Phytomedicine. https://doi.org/10.1016/j.phymed.2024.156173

Vancouver

Yu Q, Zhang L, Wang Z, Wang Q, Sun X, Deng W, et al. Anti-inflammatory oligosaccharide licensed mesenchymal stem cells allow prolonged survival of septic rats via the promotion of glutathione synthesis. Phytomedicine. 2024. doi:10.1016/j.phymed.2024.156173

BibTeX
@article{Yu2024,
  author = {Yu, Qingtong and Zhang, Linzhi and Wang, Zhe and Wang, Qilong and Sun, Xuan and Deng, Wenwen and Cao, Xia and Yu, Jiangnan and Xu, Ximing},
  title = {Anti-inflammatory oligosaccharide licensed mesenchymal stem cells allow prolonged survival of septic rats via the promotion of glutathione synthesis},
  journal = {Phytomedicine},
  year = {2024},
  doi = {10.1016/j.phymed.2024.156173}
}
Kostenlos starten →